7232Cx
Maximo VR

Device Survival Probability
7232_SURV
Loading...
1 yr | 2 yr | 3 yr | 4 yr | 5 yr | 6 yr | 7 yr | 8 yr | 9 yr | 10 yr | 11 yr | 12 yr | 13 yr | 14 yr | 15 yr | 16 yr | at 198.0 mo | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% | ![]() |
100.0 | 100.0 | 99.9 | 99.9 | 99.9 | 99.9 | 99.8 | 99.8 | 99.7 | 99.7 | 99.7 | 99.7 | 99.7 | 99.6 | 99.6 | 99.6 | 99.6 | ||||
% | ![]() |
99.8 | 99.7 | 99.3 | 98.9 | 97.6 | 92.7 | 85.8 | 75.4 | 52.4 | 27.1 | 22.3 | 21.1 | 20.0 | 19.3 | 18.3 | 17.5 | 16.4 | ||||
# | 38515 | 35189 | 31908 | 28422 | 24990 | 21599 | 18227 | 14640 | 9020 | 3682 | 2491 | 1998 | 1563 | 1218 | 879 | 463 | 155 |
- Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
- Excluding Normal Battery Depletion – This is the malfunction free survival curve.

Product Characteristics
Generator Type | ICD |
---|---|
NBD Code | VVE-VVIR |
Max. Delivered Energy | 35J |
Connector Style | Cx Style |
---|---|
Serial Number Prefix | PRN |
Mass | 76g |
Volume | 39cc |
Waveform | Biphasic |
X-Ray ID | PRN |

Cx Style

Estimated Longevity
Charging Frequency | 100% Pacing | 50% Pacing | 15% Pacing | 100% Sensing |
---|---|---|---|---|
Monthly | 4.4 | 4.7 | 4.8 | 4.9 |
Quarterly | 7.0 | 7.5 | 8.0 | 8.3 |
Semi-annual | 8.2 | 9.0 | 9.7 | 10.0 |
Longevity estimates based on the following device usage. Pacing Mode VVI; Ventricular Lower Pacing Rate 60ppm; Ventricular Pulse Width 0.4ms; Ventricular Pulse Amplitude 3V; Ventricle Impedance 510ohms; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Distribution Data
US Market Release | 2003-10-06 |
---|---|
CE Approval Date | 2003-10-28 |
Registered USA Implants | 43623 |
Estimated Active USA Implants | 2773 |
Normal Battery Depletions | 10367 |
US Market Release | 2003-10-06 |
---|---|
CE Approval Date | 2003-10-28 |
Estimated WW Distribution | 75208 |
Normal Battery Depletions | 10674 |

EOL Indication
EOL device status is defined as three months following an ERI indication assuming the following post-ERI conditions: 100% VVI pacing at 60 ppm, 3 V, 0.4 ms; 500 Ohm pacing load; and six 30 J charges. EOL may be indicated before the end of three months if the device exceeds these conditions.
Data as of November 29, 2022